Sanuwave Health Inc (SNWV) financial statements (2021 and earlier)
Company profile
| Business Address |
3360 MARTIN FARM RD SUWANEE, GA 30024 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2 | 0 | 1 | 0 | 0 | 4 | |||
| Cash and cash equivalents | 2 | 0 | 1 | 0 | 0 | 4 | |||
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Inventory, net of allowances, customer advances and progress billings | 1 | 0 | 0 | 0 | 0 | 0 | |||
| Inventory | 1 | 0 | 0 | 0 | 0 | 0 | |||
| Prepaid expense | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total current assets: | 3 | 1 | 1 | 1 | 1 | 4 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 1 | 0 | 0 | 0 | 0 | 0 | |||
| Intangible assets, net (including goodwill) | 0 | 1 | |||||||
| Intangible assets, net (excluding goodwill) | 0 | 1 | |||||||
| Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Total noncurrent assets: | 1 | 0 | 0 | 0 | 0 | 1 | |||
| TOTAL ASSETS: | 3 | 1 | 1 | 1 | 1 | 5 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6 | 4 | 3 | 1 | 1 | 1 | |||
| Accounts payable | 1 | 2 | 1 | 1 | 1 | 0 | |||
| Accrued liabilities | 1 | 1 | 1 | 0 | 0 | 0 | |||
| Employee-related liabilities | 1 | 0 | 0 | 0 | 0 | 0 | |||
| Interest and dividends payable | 2 | 1 | 1 | ||||||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 1 | 5 | 0 | 0 | |||||
| Derivative instruments and hedges, liabilities | 0 | 2 | 2 | 1 | 0 | 0 | |||
| Due to related parties | 0 | 5 | 0 | 5 | 5 | ||||
| Contract with customer, liability | ✕ | ✕ | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 6 | 1 | 6 | 0 | 0 | 0 | |||
| Total current liabilities: | 12 | 16 | 11 | 8 | 1 | 6 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | ||||||||
| Finance lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 0 | 0 | 5 | ||||||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Contract with customer, liability | ✕ | ✕ | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Due to related parties | 5 | ||||||||
| Total noncurrent liabilities: | 1 | 0 | 5 | ||||||
| Total liabilities: | 13 | 17 | 11 | 8 | 7 | 6 | |||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (10) | (15) | (10) | (7) | (6) | (2) | |||
| Preferred stock | 0 | ||||||||
| Common stock | 0 | 0 | 0 | 92 | 0 | 0 | |||
| Additional paid in capital | 115 | 101 | 95 | (99) | 87 | 87 | |||
| Accumulated other comprehensive loss | (0) | (0) | (0) | (0) | (0) | (0) | |||
| Accumulated deficit | (125) | (117) | (105) | (93) | (88) | ||||
| Warrants and rights outstanding | 2 | ||||||||
| Other undisclosed stockholders' equity attributable to parent | (2) | 0 | |||||||
| Total stockholders' equity: | (10) | (15) | (10) | (7) | (6) | (2) | |||
| TOTAL LIABILITIES AND EQUITY: | 3 | 1 | 1 | 1 | 1 | 5 | |||
Income statement (P&L) ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2 | 2 | 1 | 1 | 1 | 1 | ||
| Cost of revenue | (1) | (1) | (0) | (1) | (0) | (0) | ||
| Gross profit: | 1 | 1 | 0 | 1 | 1 | 1 | ||
| Operating expenses | (9) | (8) | (4) | (4) | (5) | (7) | ||
| Operating loss: | (8) | (7) | (4) | (3) | (4) | (6) | ||
| Nonoperating expense | (2) | (4) | (2) | (3) | (0) | (0) | ||
| Foreign currency transaction loss, before tax | (0) | (0) | (0) | (0) | (0) | (0) | ||
| Interest and debt expense | (2) | (4) | (1) | (1) | (0) | (0) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | |||||||
| Loss from continuing operations before income taxes: | (12) | (16) | (7) | (7) | (5) | (6) | ||
| Income tax benefit | 2 | |||||||
| Net loss: | (12) | (16) | (7) | (7) | (5) | (4) | ||
| Other undisclosed net income (loss) attributable to parent | 2 | 4 | 1 | 1 | 0 | (2) | ||
| Net loss available to common stockholders, diluted: | (10) | (12) | (6) | (6) | (5) | (6) | ||
Comprehensive Income ($ in millions)
| 9/30/2020 TTM | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (12) | (16) | (7) | (7) | (5) | (4) | ||
| Other comprehensive loss | (0) | (0) | ||||||
| Comprehensive loss: | (12) | (16) | (7) | (7) | (5) | (4) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2 | 4 | 1 | 1 | 0 | (2) | ||
| Comprehensive loss, net of tax, attributable to parent: | (10) | (12) | (6) | (6) | (5) | (6) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.